Table 2.
Intracellular analogue concentrations following treatment.
| Cell Line | BENSpm (nmol/mg Protein) | SBP-101 (nmol/mg Protein) |
|---|---|---|
| A549 | 29.62 | 16.13 |
| H157 | 26.87 | 31.21 |
| AsPC-1 | 39.17 | 9.79 |
| BxPC-3 | 29.13 | 19.11 |
| CaOV-3 | 17.838 | 12.608 |
| Sk-OV-3 | 24.573 | 12.199 |
Intracellular analogue concentrations following treatment.
| Cell Line | BENSpm (nmol/mg Protein) | SBP-101 (nmol/mg Protein) |
|---|---|---|
| A549 | 29.62 | 16.13 |
| H157 | 26.87 | 31.21 |
| AsPC-1 | 39.17 | 9.79 |
| BxPC-3 | 29.13 | 19.11 |
| CaOV-3 | 17.838 | 12.608 |
| Sk-OV-3 | 24.573 | 12.199 |